Piramal Life Sciences Limited engages in the research, development, and commercialization of pharmaceutical products primarily in India. It develops Cyclin Dependent Kinase and PI3 Kinase inhibitors for oncology therapy; TNF production/release inhibitors and safer NSAIDs for inflammation; insulin sensitizers and DGAT1 for diabetes/metabolic disorders; and anti-infective products, such as antibacterials and antifungals for infectious diseases. The company has drug discovery and development agreements with Eli Lilly & Co., Merck & Co., and Pierre Fabre Laboratories. Piramal Life Sciences Limited is based in Mumbai, India.
Piramal Life Sciences Live Stock Price, Share Chart, Quotes, NSE, BSE
Piramal Life Sciences Limited engages in the research, development, and commercialization of pharmaceutical products primarily in India. It develops Cyclin Dependent Kinase and PI3 Kinase inhibitors for oncology therapy; TNF production/release inhibitors and safer NSAIDs for inflammation; insulin sensitizers and DGAT1 for diabetes/metabolic disorders; and anti-infective products, such as antibacterials and antifungals for infectious diseases. The company has drug discovery and development agreements with Eli Lilly & Co., Merck & Co., and Pierre Fabre Laboratories. Piramal Life Sciences Limited is based in Mumbai, India.
